Literature DB >> 1959936

Neopterin augmentation of tumor necrosis factor production.

M Barak1, N Gruener.   

Abstract

Gamma interferon (gamma-IFN), lipopolysaccharide (LPS)-gamma or interleukin-2 (IL-2)-induced tumor necrosis factor alpha (TNF alpha) production by both macrophages and peripheral blood mononuclear cells (PBMC), was increased in the presence of neopterin. Addition of neopterin caused an increased level of TNF alpha, but did not affect the kinetics of the TNF alpha production, which showed peak levels of cytotoxic activity 4 h after stimulatory treatment. Using anticytokine antibodies, we concluded that the neopterin effect was mainly gamma-IFN mediated, and only slightly affected by anti IL-2 receptor antibodies. The neopterin augmented TNF alpha production can be attributed to an immunological role for neopterin in the enhancement of cell-mediated immune (CMI) response.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1959936     DOI: 10.1016/0165-2478(91)90096-s

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  6 in total

Review 1.  Mechanisms of action of interferon-beta in multiple sclerosis.

Authors:  B G Arnason; A Dayal; Z X Qu; M A Jensen; K Genç; A T Reder
Journal:  Springer Semin Immunopathol       Date:  1996

2.  Gamma interferon is dispensable for neopterin production in vivo.

Authors:  R Sghiri; J Feinberg; F Thabet; K Dellagi; J Boukadida; A Ben Abdelaziz; J L Casanova; M R Barbouche
Journal:  Clin Diagn Lab Immunol       Date:  2005-12

3.  Dynamic production of tumour necrosis factor-alpha (TNF-alpha) messenger RNA, intracellular and extracellular TNF-alpha by murine macrophages and possible association with protein tyrosine phosphorylation of STAT1 alpha and ERK2 as an early signal.

Authors:  Z M Zheng; S Specter
Journal:  Immunology       Date:  1996-04       Impact factor: 7.397

4.  Interleukin-2, soluble interleukin-2-receptor, neopterin, L-tryptophan and beta 2-microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic-progressive multiple sclerosis.

Authors:  M Ott; L Demisch; W Engelhardt; P A Fischer
Journal:  J Neurol       Date:  1993-12       Impact factor: 4.849

Review 5.  Anaemia of cancer: an overview of mechanisms involved in its pathogenesis.

Authors:  H Z W Grotto
Journal:  Med Oncol       Date:  2007-09-02       Impact factor: 3.064

6.  Activation of tumor necrosis factor--alpha system in HIV-1 infection: association with markers of immune activation.

Authors:  P Aukrust; N B Liabakk; F Müller; T Espevik; S S Frøland
Journal:  Infection       Date:  1995 Jan-Feb       Impact factor: 3.553

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.